
Newt Gingrich @newtgingrich
New CBO report illustrates how more pharma R&D spending leads to more new treatments, and how R&D spending is directly linked to revenue expectations. If we want continued innovation, we should focus on cutting out middlemen not govt price setting. https://t.co/Z2UlqRm9bm — PolitiTweet.org